Research
Molecular
Gene targeting of GPR75 is more effective than current pharmacologic therapies without the known side effects.
Gene targeting may provide a safer and more effective alternative to current obesity treatments.
StrongSupportsmedium confidence
Gene targeting of GPR75 is more effective than current pharmacologic therapies without the known side effects.
Why this rating
The claim is based on a review of existing knowledge.
Source
GPR75: A Newly Identified Receptor for Targeted Intervention in the Treatment of Obesity and Metabolic Syndrome
Michael Fragner et al. · Cardiology in Review · 2024
DOI 10.1097/crd.0000000000000711
reviewCited 3×
Read the paper DOI resolved against Crossref · corpus check 2026-06-10
More from this paper
Related findings · Molecular
- QRISK decreased markedly after weight loss from 18.9 ± 2.2% to 11.2 ± 1.6%, p < 0.0001.Strong
- Normalization of 10-year cardiovascular risk and heart age is possible after substantial dietary weight loss and remission of T2DM.Strong
- The Low-Fat Plus diet resulted in a greater reduction in total cholesterol compared to the Low-Fat diet, with changes of -0.46 mmol/L (-17.6 mg/dL) versus -0.24 mmol/L (-9.2 mg/dL) respectively (P = 0.01).Strong
This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →